Order Article Reprints

Assié J-B, Crépin F, Grolleau E, Canellas A, Geier M, Grébert-Manuardi A, Akkache N, Renault A, Hauss P-A, Sabatini M, et al. Immune-Checkpoint Inhibitors for Malignant Pleural Mesothelioma: A French, Multicenter, Retrospective Real-World Study. Cancers. 2022; 14(6):1498. https://doi.org/10.3390/cancers14061498

Assié, Jean-Baptiste, Florian Crépin, Emmanuel Grolleau, Anthony Canellas, Margaux Geier, Aude Grébert-Manuardi, Nabila Akkache, Aldo Renault, Pierre-Alexandre Hauss, Marielle Sabatini, and et al. 2022. "Immune-Checkpoint Inhibitors for Malignant Pleural Mesothelioma: A French, Multicenter, Retrospective Real-World Study" Cancers 14, no. 6: 1498. https://doi.org/10.3390/cancers14061498

Assié, J.-B., Crépin, F., Grolleau, E., Canellas, A., Geier, M., Grébert-Manuardi, A., Akkache, N., Renault, A., Hauss, P.-A., Sabatini, M., Bonnefoy, V., Cortot, A., Wislez, M., Gauvain, C., Chouaïd, C., Scherpereel, A., & Monnet, I. (2022). Immune-Checkpoint Inhibitors for Malignant Pleural Mesothelioma: A French, Multicenter, Retrospective Real-World Study. Cancers, 14(6), 1498. https://doi.org/10.3390/cancers14061498